Found: 42
Select item for more details and to access through your institution.
Myasthenia gravis developing in a patient with CNS lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Meningeal Carcinomatosis as the Presenting Manifestation of Gastric Adenocarcinoma.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 2, p. 329
- By:
- Publication type:
- Article
Gadolinium effect on thalamus and whole brain tissue segmentation.
- Published in:
- Neuroradiology, 2018, v. 60, n. 11, p. 1167, doi. 10.1007/s00234-018-2082-5
- By:
- Publication type:
- Article
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1177/2055217319841881
- By:
- Publication type:
- Article
Treatment of multiple sclerosis in special populations: The case of refugees.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1177/2055217319848466
- By:
- Publication type:
- Article
The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
- Published in:
- Journal of the International Neuropsychological Society, 2022, v. 28, n. 1, p. 94, doi. 10.1017/S1355617721000102
- By:
- Publication type:
- Article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211058298
- By:
- Publication type:
- Article
Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients.
- Published in:
- Scientific Reports, 2017, p. 45926, doi. 10.1038/srep45926
- By:
- Publication type:
- Article
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 221, doi. 10.1177/13524585221137502
- By:
- Publication type:
- Article
External validation of a clinical prediction model in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 261, doi. 10.1177/13524585221136036
- By:
- Publication type:
- Article
Ethical use of off-label disease-modifying therapies for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1403, doi. 10.1177/13524585211030207
- By:
- Publication type:
- Article
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1765, doi. 10.1177/1352458519881994
- By:
- Publication type:
- Article
Letter to the editor.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
- Published in:
- BMC Neurology, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2377-14-27
- By:
- Publication type:
- Article
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Vocal symptoms and acoustic changes in relation to the expanded disability status scale, duration and stage of disease in patients with multiple sclerosis.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2009, v. 266, n. 11, p. 1759, doi. 10.1007/s00405-009-1003-y
- By:
- Publication type:
- Article
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study.
- Published in:
- CNS Drugs, 2024, v. 38, n. 11, p. 921, doi. 10.1007/s40263-024-01115-x
- By:
- Publication type:
- Article
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
- Published in:
- CNS Drugs, 2021, v. 35, n. 11, p. 1217, doi. 10.1007/s40263-021-00860-7
- By:
- Publication type:
- Article
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018.
- Published in:
- CNS Drugs, 2021, v. 35, n. 10, p. 1097, doi. 10.1007/s40263-021-00833-w
- By:
- Publication type:
- Article
Human Herpesvirus 6 in Patients With Bell's Palsy.
- Published in:
- Journal of Applied Research, 2003, v. 3, n. 3, p. 239
- By:
- Publication type:
- Article
Narghile (Hubble-Bubble) Smoking, Low Birth Weight, and Other Pregnancy Outcomes.
- Published in:
- American Journal of Epidemiology, 1998, v. 148, n. 4, p. 375, doi. 10.1093/oxfordjournals.aje.a009656
- By:
- Publication type:
- Article
Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.
- Published in:
- International Journal of MS Care, 2021, v. 23, n. 6, p. 261, doi. 10.7224/1537-2073.2021-006
- By:
- Publication type:
- Article
(DXT42) Rationale and Design of CLASSIC-MS Study Evaluating Long-Term Efficacy for Patients with Multiple Sclerosis Treated with Cladribine Tablets.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 30
- By:
- Publication type:
- Article
Extracranial venous stenosis is an unlikely cause of multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 11, p. 1341, doi. 10.1177/1352458510385268
- By:
- Publication type:
- Article
Celiac disease, Behçet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2009, v. 15, n. 11, p. 1368, doi. 10.1177/1352458509345908
- By:
- Publication type:
- Article
Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries.
- Published in:
- Multiple Sclerosis International, 2013, p. 1, doi. 10.1155/2013/952321
- By:
- Publication type:
- Article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211058298
- By:
- Publication type:
- Article
Expert opinion on the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420935019
- By:
- Publication type:
- Article
Alpha-Interferon in the Treatment of Subacute Sclerosing Panencephalitis.
- Published in:
- Journal of Child Neurology, 1997, v. 12, n. 8, p. 486, doi. 10.1177/088307389701200803
- By:
- Publication type:
- Article
Impact of living and socioeconomic characteristics on cardiovascular risk in ischemic stroke patients.
- Published in:
- International Journal of Stroke, 2014, v. 9, n. 8, p. 1065, doi. 10.1111/ijs.12290
- By:
- Publication type:
- Article
Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registry.
- Published in:
- International Journal of Stroke, 2013, v. 8, p. 4, doi. 10.1111/j.1747-4949.2012.00893.x
- By:
- Publication type:
- Article
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 5, p. 1321, doi. 10.1007/s40120-024-00650-5
- By:
- Publication type:
- Article
A Patient with Combined CADASIL and MTHFR Homozygosity.
- Published in:
- Case Reports in Neurological Medicine, 2020, p. 1, doi. 10.1155/2020/4980847
- By:
- Publication type:
- Article
Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 8, p. 1026, doi. 10.1177/13524585241261565
- By:
- Publication type:
- Article
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 3, doi. 10.1177/13524585231205970
- By:
- Publication type:
- Article
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 875, doi. 10.1177/13524585231151951
- By:
- Publication type:
- Article
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 719, doi. 10.1177/13524585231161494
- By:
- Publication type:
- Article
Voice-Related Quality of Life in Patients with Multiple Sclerosis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Voice-Related Quality of Life in Patients with Multiple Sclerosis.
- Published in:
- Autoimmune Diseases (2090-0422), 2012, p. 1, doi. 10.1155/2012/143813
- By:
- Publication type:
- Article
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.
- Published in:
- Multiple Sclerosis International, 2016, p. 1, doi. 10.1155/2016/1034912
- By:
- Publication type:
- Article